Literature DB >> 11342295

Stepwise lineage restriction of progenitors in lympho-myelopoiesis.

Y Katsura1, H Kawamoto.   

Abstract

It has long been controversial whether hematopoiesis progresses through ordered stages of determination as in embryonic development. This is due to the absence of a methodology capable of exactly determining the developmental potential of hematopoietic stem/progenitor cells. The multilineage progenitor (MLP) assay enabled us to discriminate among seven types of hematopoietic progenitors, which are multipotent progenitor p-MTB (capable of generating myeloid, T and B cells), bipotent progenitors p-MT, p-MB and p-TB, and unipotent progenitors p-M, p-T and p-B. Among these seven types, the p-TB type progenitor was found to be absent. These findings indicate that the process of lineage commitment proceeds through an ordered but not random process. By extending the area of investigation to include the erythroid lineage, more convincing evidence for the ordered process was obtained. Detailed and exact illustration of the process of hematopoiesis will provide an opportunity to revive hematopoiesis as one of the most fascinating targets of research in developmental biology.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11342295     DOI: 10.3109/08830180109056720

Source DB:  PubMed          Journal:  Int Rev Immunol        ISSN: 0883-0185            Impact factor:   5.311


  10 in total

Review 1.  A developing picture of lymphopoiesis in bone marrow.

Authors:  Jun Hirose; Taku Kouro; Hideya Igarashi; Takafumi Yokota; Nobuo Sakaguchi; Paul W Kincade
Journal:  Immunol Rev       Date:  2002-11       Impact factor: 12.988

2.  Identification of a human B-cell/myeloid common progenitor by the absence of CXCR4.

Authors:  Yong-Hao Hou; Edward F Srour; Heather Ramsey; Richard Dahl; Hal E Broxmeyer; Robert Hromas
Journal:  Blood       Date:  2005-01-13       Impact factor: 22.113

Review 3.  Progression of regulatory gene expression states in fetal and adult pro-T-cell development.

Authors:  Elizabeth-Sharon David-Fung; Mary A Yui; Marissa Morales; Hua Wang; Tom Taghon; Rochelle A Diamond; Ellen V Rothenberg
Journal:  Immunol Rev       Date:  2006-02       Impact factor: 12.988

Review 4.  Transcriptional control of early T and B cell developmental choices.

Authors:  Ellen V Rothenberg
Journal:  Annu Rev Immunol       Date:  2014-01-22       Impact factor: 28.527

5.  Single-cell RNA sequencing reveals developmental heterogeneity among early lymphoid progenitors.

Authors:  Llucia Alberti-Servera; Lilly von Muenchow; Panagiotis Tsapogas; Giuseppina Capoferri; Katja Eschbach; Christian Beisel; Rhodri Ceredig; Robert Ivanek; Antonius Rolink
Journal:  EMBO J       Date:  2017-10-13       Impact factor: 11.598

Review 6.  Hematopoiesis and T-cell specification as a model developmental system.

Authors:  Ellen V Rothenberg; Hao Yuan Kueh; Mary A Yui; Jingli A Zhang
Journal:  Immunol Rev       Date:  2016-05       Impact factor: 12.988

7.  Enforced expression of EBF in hematopoietic stem cells restricts lymphopoiesis to the B cell lineage.

Authors:  Zheng Zhang; Claudiu V Cotta; Robert P Stephan; Cristina G deGuzman; Christopher A Klug
Journal:  EMBO J       Date:  2003-09-15       Impact factor: 11.598

8.  Homologous lactoferrin triggers mobilization of the myelocytic lineage of bone marrow in experimental mice.

Authors:  Michał Zimecki; Jolanta Artym; Maja Kocięba; Katarzyna Kaleta-Kuratewicz; Piotr Kuropka; Jan Kuryszko; Marian Kruzel
Journal:  Stem Cells Dev       Date:  2013-08-24       Impact factor: 3.272

9.  Establishment of self-renewable GM-CSF-dependent immature macrophages in vitro from murine bone marrow.

Authors:  Sachiko Ito; Yuriko Tanaka; Naomi Nishio; Suganya Thanasegaran; Ken-Ichi Isobe
Journal:  PLoS One       Date:  2013-10-04       Impact factor: 3.240

10.  Inferring cell differentiation processes based on phylogenetic analysis of genome-wide epigenetic information: hematopoiesis as a model case.

Authors:  Kanako O Koyanagi
Journal:  Genome Biol Evol       Date:  2015-01-31       Impact factor: 3.416

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.